Financials
- Market Capitalization 1.9 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1992 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.20 USD | -1.11% | -4.41% | +28.60% | +105.31% | 1.96 B USD | ||
| 1997 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.98 USD | -0.52% | -5.01% | +16.51% | -15.46% | 1.96 B USD | ||
| 2012 | SION Sionna Therapeutics, Inc. - Common Stock | 42.39 USD | -0.47% | -8.13% | +17.72% | +7.75% | 1.91 B USD | ||
| 2025 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.50 USD | -1.76% | +2.31% | +25.61% | +102.63% | 1.88 B USD |